# Filing Detail

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001144204-14-057292
Filing Date
2014-09-23
Accepted
2014-09-23 12:21:21
Documents
11
Period of Report
2014-09-23

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 6-K | v389832_6-k.htm | 6-K | 47286
2 | EXHIBIT 99.1 | v389832_ex99-1.htm | EX-99.1 | 4890
3 | EXHIBIT 99.2 | v389832_ex99-2.htm | EX-99.2 | 42079
4 | GRAPHIC | ex1_001.jpg | GRAPHIC | 197839
5 | GRAPHIC | ex1_002.jpg | GRAPHIC | 290085
6 | GRAPHIC | ex1_003.jpg | GRAPHIC | 15000
7 | GRAPHIC | ex1_004.jpg | GRAPHIC | 363006
8 | GRAPHIC | ex1_005.jpg | GRAPHIC | 308321
9 | GRAPHIC | ex1_006.jpg | GRAPHIC | 250718
10 | GRAPHIC | ex1_007.jpg | GRAPHIC | 212621
11 | GRAPHIC | image_001.jpg | GRAPHIC | 2946
| Complete submission text file | 0001144204-14-057292.txt |  | 2356666

Mailing Address 85 MEDINAT HAYEHUDIM ST. PITUACH, PO BOX 4033 HERZLIYA L3 46140
Business Address XTL BIOPHARMACEUTICALS LTD C/O ALSTON & BIRD LLP, 90 PARK AVENUE NEW YORK NY 10016 972 9 955 7080
XTL BIOPHARMACEUTICALS LTD (Filer) CIK: 0001023549 (see all company filings)

EIN.: 000000000
Type: 6-K | Act: 34 | File No.: 001-36000 | Film No.: 141115542
SIC: 2834 Pharmaceutical Preparations